Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Grant H. Hickok

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-8235-4773; OpenAlex author ID A5092385326; NIH RePORTER profile ID 80227413. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
1
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers, 1 grant

Papers 4

  1. Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adz4302↗
  2. Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2026-015489↗
  3. IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2326-6066.cir-24-0758↗
  4. Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2023.112732↗

Grants 1

  1. Elucidating the Role of CD8+ TCR Attributes in Cancer Immunotherapy F31CA310226↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingunn M. Stromnes · 4 shared papers, 2023–2026 · strength 0.80
  2. Adam L. Burrack · 4 shared papers, 2023–2026 · strength 0.80
  3. Zoe C. Schmiechen · 4 shared papers, 2023–2026 · strength 0.80
  4. Alexander K. Tsai · 3 shared papers, 2025–2026 · strength 0.64
  5. Cara-lin Lonetree · 2 shared papers, 2025–2026 · strength 0.41
  6. David Masopust · 1 shared paper, 2026 · strength 0.23
  7. Paolo Provenzano · 1 shared paper, 2026 · strength 0.23
  8. Guhan Qian · 1 shared paper, 2026 · strength 0.23
  9. Philip D. Greenberg · 1 shared paper, 2026 · strength 0.23
  10. Sunil R. Hingorani · 1 shared paper, 2026 · strength 0.23
  11. Liang‐I Kang · 1 shared paper, 2026 · strength 0.22
  12. David G DeNardo · 1 shared paper, 2026 · strength 0.22
  13. Michael T. Patterson · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.